Telomir Pharmaceuticals, Inc. SEC filings TELO
Telomir Pharmaceuticals, Inc. has 149 filings in SEC EDGAR's recent list, going back to Apr 3, 2023. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Jul 27, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Apr 16, 2026 |
| 3 | Initial insider ownership | Jun 9, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 21, 2026 |
| 4 | Insider transaction | Apr 24, 2026 | Apr 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| 3 | Initial insider ownership | Oct 3, 2025 | Sep 29, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 18, 2025 | — |
| 3 | Initial insider ownership | Jun 10, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 30, 2025 | May 28, 2025 |
| 5 | Annual insider ownership | Feb 4, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Nov 25, 2024 | Nov 21, 2024 |
| 4 | Insider transaction | Sep 4, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 27, 2024 |
| 4 | Insider transaction | Aug 29, 2024 | Aug 27, 2024 |
| 3 | Initial insider ownership | Aug 29, 2024 | Jun 18, 2024 |
| 3 | Initial insider ownership | Aug 15, 2024 | Aug 8, 2024 |
| 3 | Initial insider ownership | Aug 15, 2024 | Aug 8, 2024 |
| 3 | Initial insider ownership | Aug 15, 2024 | Aug 8, 2024 |
| 3 | Initial insider ownership | Aug 15, 2024 | Aug 8, 2024 |
| 4 | Insider transaction | Feb 15, 2024 | Feb 13, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
| 3 | Initial insider ownership | Feb 8, 2024 | Feb 8, 2024 |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TELO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1971532
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.